|
Gene Banucci has led ATMI, Inc. (Nasdaq: ATMI) as Chairman and CEO since co-founding the Company in 1986. He, along with the founding team of scientists, had a vision of creating a preeminent semiconductor materials company. The company went public in 1993 with only $7 million in revenues, and grew to $300 million in 2000 due to an aggressive technology development and M&A strategy. As a result of the technology downturn of 2001-2002, Gene initiated a major strategic realignment of the Company that led to the divestment of over one-third of the Company’s product lines while simultaneously growing the Company’s core business over 40%. At the beginning of 2005, Gene decided to make strategy, investor relations and governance his primary activities and moved to an executive Chairman role with the Company. ATMI exited 2006 with over $325 million in revenues and a market capitalization in excess of $1 billion. Prior to starting ATMI, Gene served as Vice President for American Cyanamid’s Chemical Research Division, where he directed more than 800 scientists and engineers in new product research and development for this $1.4 billion unit. Previously, he was with General Electric Company for over 10 years in a variety of management positions at the Corporate R&D Center and GE Plastics. Gene is a founding member of the Connecticut Technology Council, a member of the Board of the Program on Innovation and Technology of the National Research Council, a member of the Board of Directors of Zygo, Inc. (Nasdaq:ZIGO), Clean Harbors (Nasdaq:CLHB), and a member of the Board of Trustees of Beloit College. He received his PhD in Organic Chemistry from Wayne State University, and his BA in Chemistry from Beloit College. Gene holds 22 issued U.S. patents and is the author of numerous published articles. Gene was awarded the Connecticut Medal of Technology in October of 2006. | 